Gland Pharma
Gland Pharma Ltd is an Indian injectable pharmaceutical contract manufacturing company producing sterile injectables, complex generic drugs, and oncology formulations globally. Operating as a subsidiary of China's Shanghai Fosun Pharmaceutical, the company formulates and manufactures vial injectables, pre-filled syringes, ampoules, and lyophilized powders across B2B CDMO arrangements. Principal revenues derive from contract manufacturing sales, supply agreements, and royalty profit shares with global pharmaceutical brand owners. Core end markets encompass multinational generic pharmaceutical companies, hospital procurement networks, and clinical healthcare systems across North America, Europe, India, and emerging markets. Gland Pharma holds a market-leading global position as a specialized pure-play manufacturer of sterile generic injectable pharmaceuticals. The company is headquartered in Hyderabad, India, and its equity shares trade on the BSE and National Stock Exchange of India.
3 of the funds FundTelligence covers report a position in Gland Pharma.
- Legal name
- Gland Pharma Ltd
- Sector
- Health Care
- Country
- India
- Funds holding it
- 3
Funds holding Gland Pharma
- Schroder Indian Opportunities — Schroders · 1.7 % (largest positions only, October 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)